| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.19 | 0.0001 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0005 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |